✦ LIBER ✦

STENT THROMBOSIS FOLLOWING IMPLANTATION OF ENDEAVOR ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH COMPLEX CORONARY LESIONS – INSIGHTS FROM THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL

✍ Scribed by Costa, Ricardo A.; Abizaid, Alexandre; Bhatt, Deepak; Paula, Joao E. Tinoco de; Siqueira, Dimytri; Devito, Fernando; Marin-Neto, J. Antonio; Botelho, Roberto; Castello, Helio; Mangione, José; Meireles, George; Centemero, Marinella; Tanajura, Luiz; Abizaid, Andrea; Feres, Fausto

Book ID: 123502860
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 182 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(14)61909-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

IMPACT OF SHORT- VERSUS LONG-TERM DAPT I

IMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS – A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL

✍ Feres, Fausto; Costa, Ricardo; Bhatt, Deepak; De Paula, Joao; Botelho, Roberto; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 183 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Optimized Duration of Clopidogrel Therap

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

✍ Fausto Feres; Ricardo A. Costa; Deepak L. Bhatt; Martin B. Leon; Roberto V. Bote 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

OPTIMIZED DURATION OF CLOPIDOGREL THERAP

OPTIMIZED DURATION OF CLOPIDOGREL THERAPY FOLLOWING TREATMENT WITH THE ENDEAVOR ZOTAROLIMUS-ELUTING STENTS IN THE REAL-WORLD CLINICAL PRACTICE (OPTIMIZE) TRIAL: RATIONALE, DESIGN AND PRELIMINARY RESULTS OF A LARGE-SCALE, RANDOMIZED, MULTICENTER STUDY

✍ Feres, Fausto; Costa, Ricardo A.; Abizaid, Alexandre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 117 KB